Lampo, DVM, is the EU Head of Preclinical Project Development within the
department of Preclinical Development and Safety at Janssen R&D.
Ann obtained the degree of Doctor in Veterinary Medicine at the University of
Ghent Belgium in 1987. She was certified in European Regulatory Affairs at the
Institute for Pharmaceutical Business Administration in the Netherlands (1996)
and is a Eurotox Registered Toxicologist since 1998.
joined Janssen in 1988 as a Scientific writer. In 2000, she was appointed
Director in Toxicology and became more broadly involved in Preclinical
Development (PCD) projects, which led to the approval of a few compounds within
the Neuroscience space.
As a member of several Early Development teams, she was responsible for the
toxicological contribution of more than 50 First-in Human packages.
Since 2007, Ann is the Therapeutic Area Point of Contact for Neuroscience, Infectious
Diseases including Vaccines, and Global Public Health. In this function, she
heads up the Preclinical Project Leaders group based in Beerse. This team also
provides Preclinical Submission support for projects from NS, IDV and GPH.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.